1283 related articles for article (PubMed ID: 32959897)
1. CRISPR/Cas gene therapy.
Zhang B
J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.
Sharma G; Sharma AR; Bhattacharya M; Lee SS; Chakraborty C
Mol Ther; 2021 Feb; 29(2):571-586. PubMed ID: 33238136
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
5. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9 in genome editing: Its function and medical applications.
Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
[TBL] [Abstract][Full Text] [Related]
7. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
[TBL] [Abstract][Full Text] [Related]
8. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 Probing of Infectious Diseases and Genetic Disorders.
Ramalingam S; Thangavel S
Indian J Pediatr; 2019 Dec; 86(12):1131-1135. PubMed ID: 31367975
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Genome Editing by CRISPR/Cas9-Mediated Strategy to Cure Genetic Disorders in Humans: Guide for Molecular Surgeons.
Ergoren MC; Idlibi R
Crit Rev Eukaryot Gene Expr; 2019; 29(5):387-399. PubMed ID: 32421996
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
13. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
[TBL] [Abstract][Full Text] [Related]
14. Dead Cas Systems: Types, Principles, and Applications.
Brezgin S; Kostyusheva A; Kostyushev D; Chulanov V
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801211
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
18. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
Zhang Y; Karakikes I
Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of CRISPR-Cas9 system for gene therapy].
Zhan C; Xia X
Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]